Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. The closure device may have an outer band, an inner band and a cover wherein a perimeter edge of the cover may be fastened between the outer band and the inner band. The negotiation may include, for example, acceptance of control, rejection of control, specification of resources subject to or exempt from control, and priority-based decisions to override or refrain from overriding rejections.